Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 320970011000036117 | lignocaine hydrochloride anhydrous 2% (400 mg/20 mL) injection, 30 x 20 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 320971011000036112 | lignocaine hydrochloride anhydrous 400 mg / 20 mL injection, 30 x 20 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lignocaine hydrochloride anhydrous 2% (400 mg/20 mL) injection, 30 x 20 mL ampoules | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| lignocaine hydrochloride anhydrous 2% (400 mg/20 mL) injection, 30 x 20 mL ampoules | has MPUU | lidocaine hydrochloride 2% (400 mg/20 mL) injection, ampoule | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lignocaine Hydrochloride (Pfizer (Perth)) (lignocaine hydrochloride anhydrous 400 mg / 20 mL) injection: solution, 30 x 20 mL ampoules (trade product pack) | Is a | False | lignocaine hydrochloride anhydrous 2% (400 mg/20 mL) injection, 30 x 20 mL ampoules | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR